摘要 |
It is the embodiment of this invention to form novel compositions of Indoleamines e.g. 5-Hydroxytryptophan (5HTP) and/or Catecholamines e.g. L-Dopa with the gallocatechins e.g. (-)epigallocatechin3-O-gallate (EGCG) and/or (-) epigallocatechin (EGC) or any of the catechins found in green tea in a pharmaceutical or nutritional dosage or dietary regimen be it in tablet, liquid, capsule, injectable or any other ingestible form to achieve enhanced bioavailability and a superior safety profile.
|